76 related articles for article (PubMed ID: 21530542)
21. Hormone selectivity in thyroid hormone receptors.
Wagner RL; Huber BR; Shiau AK; Kelly A; Cunha Lima ST; Scanlan TS; Apriletti JW; Baxter JD; West BL; Fletterick RJ
Mol Endocrinol; 2001 Mar; 15(3):398-410. PubMed ID: 11222741
[TBL] [Abstract][Full Text] [Related]
22. Resistance to thyroid hormone (RTH) syndrome reveals novel determinants regulating interaction of T3 receptor with corepressor.
Yoh SM; Privalsky ML
Mol Cell Endocrinol; 2000 Jan; 159(1-2):109-24. PubMed ID: 10687857
[TBL] [Abstract][Full Text] [Related]
23. SNP mutations occurring in thyroid hormone receptor influenced individual susceptibility to triiodothyronine: Molecular dynamics and site-directed mutagenesis approaches.
Liu Y; Qu K; Hai Y; Li X; Zhao L; Zhao C
J Cell Biochem; 2018 Mar; 119(3):2604-2616. PubMed ID: 29024007
[TBL] [Abstract][Full Text] [Related]
24. Identification of a new hormone-binding site on the surface of thyroid hormone receptor.
Souza PC; Puhl AC; Martínez L; Aparício R; Nascimento AS; Figueira AC; Nguyen P; Webb P; Skaf MS; Polikarpov I
Mol Endocrinol; 2014 Apr; 28(4):534-45. PubMed ID: 24552590
[TBL] [Abstract][Full Text] [Related]
25. Analysis of agonist and antagonist effects on thyroid hormone receptor conformation by hydrogen/deuterium exchange.
Figueira AC; Saidemberg DM; Souza PC; Martínez L; Scanlan TS; Baxter JD; Skaf MS; Palma MS; Webb P; Polikarpov I
Mol Endocrinol; 2011 Jan; 25(1):15-31. PubMed ID: 21106879
[TBL] [Abstract][Full Text] [Related]
26. Dynamics of nuclear receptor Helix-12 switch of transcription activation by modeling time-resolved fluorescence anisotropy decays.
Batista MR; Martínez L
Biophys J; 2013 Oct; 105(7):1670-80. PubMed ID: 24094408
[TBL] [Abstract][Full Text] [Related]
27. Glucocorticoid receptor point mutation V571M facilitates coactivator and ligand binding by structural rearrangement and stabilization.
Carlsson P; Koehler KF; Nilsson L
Mol Endocrinol; 2005 Aug; 19(8):1960-77. PubMed ID: 15774500
[TBL] [Abstract][Full Text] [Related]
28. Characterization of suramin binding sites on the human group IIA secreted phospholipase A2 by site-directed mutagenesis and molecular dynamics simulation.
Aragão EA; Vieira DS; Chioato L; Ferreira TL; Lourenzoni MR; Silva SR; Ward RJ
Arch Biochem Biophys; 2012 Mar; 519(1):17-22. PubMed ID: 22248627
[TBL] [Abstract][Full Text] [Related]
29. Molecular dynamics simulations reveal multiple pathways of ligand dissociation from thyroid hormone receptors.
Martínez L; Sonoda MT; Webb P; Baxter JD; Skaf MS; Polikarpov I
Biophys J; 2005 Sep; 89(3):2011-23. PubMed ID: 15980170
[TBL] [Abstract][Full Text] [Related]
30. Activation helix orientation of the estrogen receptor is mediated by receptor dimerization: evidence from molecular dynamics simulations.
Fratev F
Phys Chem Chem Phys; 2015 May; 17(20):13403-20. PubMed ID: 25927714
[TBL] [Abstract][Full Text] [Related]
31. Molecular basis for dimer formation of TRbeta variant D355R.
Jouravel N; Sablin E; Togashi M; Baxter JD; Webb P; Fletterick RJ
Proteins; 2009 Apr; 75(1):111-7. PubMed ID: 18798561
[TBL] [Abstract][Full Text] [Related]
32. PPARγ helix 12 exhibits an antagonist conformation.
Fratev F
Phys Chem Chem Phys; 2016 Apr; 18(13):9272-80. PubMed ID: 26975214
[TBL] [Abstract][Full Text] [Related]
33. Ligand selectivity by seeking hydrophobicity in thyroid hormone receptor.
Borngraeber S; Budny MJ; Chiellini G; Cunha-Lima ST; Togashi M; Webb P; Baxter JD; Scanlan TS; Fletterick RJ
Proc Natl Acad Sci U S A; 2003 Dec; 100(26):15358-63. PubMed ID: 14673100
[TBL] [Abstract][Full Text] [Related]
34. Structural modeling of high-affinity thyroid receptor-ligand complexes.
de Araujo AS; Martínez L; de Paula Nicoluci R; Skaf MS; Polikarpov I
Eur Biophys J; 2010 Oct; 39(11):1523-36. PubMed ID: 20512645
[TBL] [Abstract][Full Text] [Related]
35. Structural Insights into the Ligand Binding Domain of the Glucocorticoid Receptor: A Molecular Dynamics Study.
Alves NRC; Pecci A; Alvarez LD
J Chem Inf Model; 2020 Feb; 60(2):794-804. PubMed ID: 31689103
[TBL] [Abstract][Full Text] [Related]
36. Exploring Flexibility of Progesterone Receptor Ligand Binding Domain Using Molecular Dynamics.
Zheng L; Lin VC; Mu Y
PLoS One; 2016; 11(11):e0165824. PubMed ID: 27824891
[TBL] [Abstract][Full Text] [Related]
37. Design of thyroid hormone receptor antagonists from first principles.
Webb P; Nguyen NH; Chiellini G; Yoshihara HA; Cunha Lima ST; Apriletti JW; Ribeiro RC; Marimuthu A; West BL; Goede P; Mellstrom K; Nilsson S; Kushner PJ; Fletterick RJ; Scanlan TS; Baxter JD
J Steroid Biochem Mol Biol; 2002 Dec; 83(1-5):59-73. PubMed ID: 12650702
[TBL] [Abstract][Full Text] [Related]
38. Molecular modeling and molecular dynamics simulation studies on thyroid hormone receptor from Rattus norvegicus: role of conserved water molecules.
Mukherjee S; Dasgupta S; Adhikari U; Panja SS
J Mol Model; 2021 Apr; 27(5):126. PubMed ID: 33834296
[TBL] [Abstract][Full Text] [Related]
39. Mapping allostery through computational glycine scanning and correlation analysis of residue-residue contacts.
Johnson QR; Lindsay RJ; Nellas RB; Fernandez EJ; Shen T
Biochemistry; 2015 Feb; 54(7):1534-41. PubMed ID: 25658131
[TBL] [Abstract][Full Text] [Related]
40. The design of high affinity human PD-1 mutants by using molecular dynamics simulations (MD).
Du J; Qin Y; Wu Y; Zhao W; Zhai W; Qi Y; Wang C; Gao Y
Cell Commun Signal; 2018 Jun; 16(1):25. PubMed ID: 29879980
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
